Dendritic polymer macromolecular carriers for drug delivery.
about
Occupational exposure to nanomedical applicationsNanocarriers Usage for Drug Delivery in Cancer TherapyNanodiamonds: The intersection of nanotechnology, drug development, and personalized medicineDendrimers bind antioxidant polyphenols and cisplatin drugNanoparticle toxicity by the gastrointestinal route: evidence and knowledge gapsBiogenic and synthetic polyamines bind cationic dendrimersEnhanced optical breakdown in KB cells labeled with folate-targeted silver-dendrimer composite nanodevices.Poly(amidoamine) dendrimers on lipid bilayers I: Free energy and conformation of binding.Recent progress in the construction of cavity-cored supramolecular metallodendrimers via coordination-driven self-assembly.Coordination-Driven Self-Assembly of Carbazole-Based Metallodendrimers with Generation-Dependent Aggregation-Induced Emission Behavior.Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity.Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement.PAMAM dendrimers and branched polyethyleneglycol (nanoparticles) prodrugs of (-)-beta-D-(2R, 4R)-dioxolane-thymine (DOT) and their anti-HIV activity.Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivoA quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.Controlled fabrication of hierarchically branched nanopores, nanotubes, and nanowiresTargeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approachMethotrexate delivery via folate targeted dendrimer-based nanotherapeutic platform.Bioengineering strategies for designing targeted cancer therapiesPoly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient.Luminescence targeting and imaging using a nanoscale generation 3 dendrimer in an in vivo colorectal metastatic rat model.Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.Kinetically controlled cellular interactions of polymer-polymer and polymer-liposome nanohybrid systems.mPEG-PAMAM-G4 nucleic acid nanocomplexes: enhanced stability, RNase protection, and activity of splice switching oligomer and poly I:C RNA.PAMAM-camptothecin conjugate inhibits proliferation and induces nuclear fragmentation in colorectal carcinoma cells.Enhanced potency of nucleotide-dendrimer conjugates as agonists of the P2Y14 receptor: multivalent effect in G protein-coupled receptor recognition.Applications of orthogonal "click" chemistries in the synthesis of functional soft materials.Synthesis and characterization of dendritic star-shaped zwitterionic polymers as novel anticancer drug delivery carriers.Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.Dendrimeric micelles for controlled drug release and targeted delivery.The role of ganglioside GM1 in cellular internalization mechanisms of poly(amidoamine) dendrimers.Poly(amidoamine) dendrimers on lipid bilayers II: Effects of bilayer phase and dendrimer termination.Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?Subcellular Behaviour Evaluation of Nanopharmaceuticals with Aggregation-Induced Emission Molecules.Coarse-grained molecular dynamics studies of the concentration and size dependence of fifth- and seventh-generation PAMAM dendrimers on pore formation in DMPC bilayer.Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriersNanoparticles in drug delivery and environmental exposure: same size, same risks?Dendritic systems in drug delivery applications.Organized polysaccharide fibers as stable drug carriers.
P2860
Q23923393-67667CE9-B32F-4197-A8C4-C4473B26C69BQ26740048-B01FB68B-5704-4B62-8B4A-2B909482A480Q26776095-4ECC2478-2B8A-4E98-B0E6-5B1417B47F4BQ27307187-A5F1FBA7-5A68-47A9-B1C6-CA3ADFA16703Q28390761-3EF339F4-B3DE-43E4-985F-62722FDACF03Q28482718-41A63F8D-0E88-458B-817A-15F7CF15C7DDQ30471052-9C7505B7-1737-40A5-841F-BAB047594F10Q30496206-BE4F1701-D1AE-4791-9C92-29074958338DQ30689640-355B27C1-EE9E-4454-B320-ED15F3E0E94DQ30982975-14DEF0BD-9F19-48D1-8214-74C4EA83E633Q31161948-5320092D-6D2B-4409-8CA1-0C19111810A9Q31169933-F3D89870-AECD-414B-A272-6D9FBB0DFD73Q33270151-9310DB73-947E-4131-BD16-F7ED5CBC3FBCQ33640555-1E5B5438-09A2-4F04-BED9-9552BA7A3463Q33718722-DE2BDA3E-5F16-42C6-8365-FE6C2A126FECQ33821600-F2BE1C31-AF95-4449-B7D3-D18E28CD773BQ33941281-3DFDD85D-7F8A-4F94-8050-20462C75E702Q34152021-AFFE7AF4-7F57-4B82-BDB3-BF199550EFFBQ34194191-AE64A64A-7FA5-49E0-AD4C-0E15595B58ADQ34476287-493E089C-34A9-42E7-8FCA-3C61CA03B331Q34539866-B9DEE88D-364D-48CD-9369-A25AF59A4C81Q34666766-489E2395-CAA6-46A5-813C-49D198C068D3Q34687401-7B7AD213-C6DE-49CC-9C9E-492B185BB00AQ34972145-08963C3A-DEB2-4033-B09D-5F3DD1AE65B2Q34974038-0249615E-2AB7-41EB-A349-E4A90267F625Q35020387-B86E9A82-FAC9-4FFC-A013-C825EE396D4FQ35190403-9B208890-0E7C-452C-B6BC-C0A40FA7AF94Q35207056-EA0FEA82-9103-4696-B1D6-67CF36CBE431Q35488068-FE913FFE-0ED9-47D7-838D-E838B302D60CQ35552351-06252013-9057-4611-B725-F205B0A11D0FQ36212182-ABC22756-7A39-42F5-BB39-36FD073FAC94Q36270676-31EBB7AE-C0A0-4CB0-AAC4-65E40A4228B8Q36611101-32022429-2474-4E78-A904-F27CD9FDC3FCQ36662084-854A7366-4E78-4BD7-8E60-392A748969DAQ36752542-BA9F27DD-78B8-4CDD-87DA-E67D27AD5450Q36825048-CC568A1C-6C98-4F22-80E0-6337370C8CBDQ36831931-7881DD73-FEA4-42ED-AEDF-1A2D8D7A2027Q36917908-46EC90AE-9314-4D31-82DA-E1FFC8423F2FQ36945843-EF3E452A-96EB-42D0-BFB8-315AD5304F1BQ36982139-48027FDA-11EF-4E20-8E92-A3CC86AF614D
P2860
Dendritic polymer macromolecular carriers for drug delivery.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dendritic polymer macromolecular carriers for drug delivery.
@ast
Dendritic polymer macromolecular carriers for drug delivery.
@en
Dendritic polymer macromolecular carriers for drug delivery.
@nl
type
label
Dendritic polymer macromolecular carriers for drug delivery.
@ast
Dendritic polymer macromolecular carriers for drug delivery.
@en
Dendritic polymer macromolecular carriers for drug delivery.
@nl
prefLabel
Dendritic polymer macromolecular carriers for drug delivery.
@ast
Dendritic polymer macromolecular carriers for drug delivery.
@en
Dendritic polymer macromolecular carriers for drug delivery.
@nl
P2093
P1476
Dendritic polymer macromolecular carriers for drug delivery.
@en
P2093
Anil K Patri
István J Majoros
James R Baker
P304
P356
10.1016/S1367-5931(02)00347-2
P577
2002-08-01T00:00:00Z